Growth Metrics

ImmunityBio (IBRX) Net Income towards Common Stockholders Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -58.11%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -95.76%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -290.15%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 59.59%
7 Evaxion A 64.16 Bn 64.14 Bn - -129.68%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,228.66%
10 ImmunityBio 7.72 Bn 7.34 Bn 43.97 Mn -387.89%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -387.89%
Dec 31, 2025 -4.70%
Sep 30, 2025 21.55%
Jun 30, 2025 31.19%
Mar 31, 2025 3.30%
Dec 31, 2024 74.65%
Sep 30, 2024 10.34%
Jun 30, 2024 2.63%
Mar 31, 2024 -15.05%
Dec 31, 2023 -115.47%
Sep 30, 2023 13.96%
Jun 30, 2023 -45.74%
Mar 31, 2023 -13.19%
Dec 31, 2022 -18.32%
Sep 30, 2022 -25.71%
Jun 30, 2022 -6.10%
Mar 31, 2022 -27.98%
Dec 31, 2021 -33.51%
Sep 30, 2021 -33.64%
Jun 30, 2021 -71.84%
Mar 31, 2021 -115.03%
Dec 31, 2020 37.67%
Sep 30, 2020 -324.68%
Jun 30, 2020 -211.82%
Mar 31, 2020 -109.26%
Dec 31, 2019 -243.66%
Sep 30, 2019 34.08%
Jun 30, 2019 39.85%
Mar 31, 2019 35.01%
Dec 31, 2018 412.73%
Sep 30, 2018 1.39%
Jun 30, 2018 -18.25%
Mar 31, 2018 -12.25%
Dec 31, 2017 -1.03%
Sep 30, 2017 24.86%
Jun 30, 2017 31.02%
Mar 31, 2017 20.09%
Dec 31, 2016 -111.62%
Sep 30, 2016 31.13%
Jun 30, 2016 74.03%
Mar 31, 2016 6.61%
Dec 31, 2015 7,728.01%
Sep 30, 2015 -5,068.75%
Jun 30, 2015 -9,276.29%
Mar 31, 2015 -3,876.88%